“In Vivo Delivery of Nucleic Acid-Formulated Microparticles as a Potential Tolerogenic Vaccine for Type 1 Diabetes ” (2023) The Review of Diabetic Studies, 9(4). Available at: https://diabeticstudies.org/index.php/RDS/article/view/184 (Accessed: 13 September 2025).